Senior insider sale
LINEAGE CELL THERAPEUTICS, INC. — senior position signals high conviction
$193.5K
140K shares
What this filing means
BAILEY DON M plans to sell 140K shares of LINEAGE CELL THERAPEUTICS, INC. valued at approximately $193.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/24/2025ACC: 0001950047-25-007493
Director
Since Mar 2019
140K
Shares to sell
$193.5K
Approx. market value
60K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/24/2025
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/24/2025 | Stock Option Exercise Cash | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
80K
Market value
$97.5K
9/10/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
60K
Market value
$96.0K
9/24/2025
Total
Units
140K
Value
$193.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/10/2025 | 80K | $97.5K | — | Completed |
| Planned — Approximate Date | ||||
9/24/2025 | 60K | $96.0K | NYSE | Planned |
| Total | 140K | $193.5K | ||